37024
document
Efficacy of latanoprost when stored at room temperature . We compared the ocular hypotensive effect for 24 hours and the tolerability of latanoprost stored at 4 degrees C and 30 degrees C. Seventeen healthy volunteers were included in this crossover trial . Latanoprost 0.005 % ( Xalatan ) was stored at 4 degrees C or 30 degrees C for 4 weeks in the dark . The subjects enrolled to the study were randomly assigned to receive either latanoprost stored at 4 degrees C or that stored at 30 degrees C. The eye drop was applied to the right eye of each subject for 3 days . The left eye served as a control without administration . Slit-lamp biomicroscopy and circadian intra ocular pressure ( IOP ) curve was performed at Day 3 , every 3 hours from 6 pm . This procedure was repeated 7 days after changing the drug from 4 degrees C to 30 degrees C or vice versa , and application to the left eye for 3 days . Eyes treated with latanoprost , stored both at 4 degrees C and 30 degrees C , achieved statistically significantly lower mean IOPs than untreated eyes at all time points , except at 21 hours treated by the drug stored at 30 degrees C. We subtracted the IOP of eyes receiving latanoprost from the IOP of untreated eyes for each time point to evaluate the efficacy of the eye drops ( delta IOP ) . There were no statistically significant differences between the delta IOPs with the drug stored at 4 degrees C and 30 degrees C. During the study , no subject developed a serious adverse event . These results suggest that latanoprost stored at 30 degrees C for 4 weeks after opening the bottle remains as effective and safe as latanoprost stored under cold conditions .
37025
Intervention_Pharmacological
latanoprost
37026
Intervention_Pharmacological
latanoprost
37027
Intervention_Pharmacological
Latanoprost
37028
Intervention_Pharmacological
Xalatan
37029
Intervention_Pharmacological
latanoprost
37030
Intervention_Surgical
Slit-lamp biomicroscopy
37031
Intervention_Physical
circadian intra ocular pressure ( IOP ) curve
37032
Outcome_Other
Efficacy
37033
Outcome_Physical
effect
37034
Outcome_Physical
statistically significantly lower mean IOPs
37035
Outcome_Other
efficacy
37036
Outcome_Physical
no statistically significant differences between the delta IOPs with the drug stored
37037
Outcome_Adverse-effects
no subject developed a serious adverse event .
37038
Outcome_Other
4 weeks after opening the bottle remains as effective and safe
37039
Participant_Sample-size
Seventeen healthy volunteers